Andrew S. Davis - 03 Oct 2022 Form 4 Insider Report for Silk Road Medical Inc

Role: Chief Commercial Officer
Signature: /s/Mhairi Jones, by power of attorney
Issuer symbol: N/A
Transactions as of: 03 Oct 2022
Net transactions value: -$292,405
Form type: 4
Filing time: 05 Oct 2022, 20:36:43 UTC
Previous filing: 02 Sep 2022
Next filing: 01 Nov 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SILK	Common Stock	Options Exercise	$9,859	+6,753	+6.9%	$1.46^*	104,958	03 Oct 2022	Direct	F1
transaction	SILK	Common Stock	Sale	$302,264	-6,753	-6.4%	$44.76	98,205	03 Oct 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SILK	Option (right to buy)	Options Exercise	$0	-6,753	-42%	$0.000000	9,239	03 Oct 2022	Common Stock	6,753	$1.46	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on May 20, 2022.
F2	All of the shares subject to this option are fully vested and exercisable as of the date hereof.